Hanefeld M, et al.: Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year followup. Diabetologia 1996; 39: 1577-1583.
Chiasson JL, et al.: STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial, JAMA 2003; 290: 486-494.
Henefeld M, et al.: Acarbose reduces the risk for myocardial infarction in type 2 diabetec patients: meta-analysis of seven long-term studies. Eur Heart 2004; 25(1): 10-16.